top of page
All Posts


Tissue Product or 510(k)/BLA? An overview of the FDA Regulations
In the world of biologics, understanding how the FDA classifies human-derived products is crucial. Whether a product is regulated as a ...


Amniotic Essence and Exosome Lore: FDA's Position We Explore
In recent years, the FDA has increased scrutiny on products derived from exosomes and amniotic fluid due to concerns about ...


Revisiting Demineralized Bone Matrix (DBM): Is This Workhorse Biologic Underutilized in Spine Surgery Compared to Synthetics and Other Allografts?
Revisiting Demineralized Bone Matrix (DBM): Is This Workhorse Biologic Underutilized in Spine Surgery Compared to Synthetics and Other...
bottom of page
